Open Access Research article

Modulation of macrophage cytokine profiles during solid tumor progression: susceptibility to Candida albicans infection

Marcela R Camargo12, James Venturini12, Fátima R Vilani-Moreno3 and Maria Sueli P Arruda1*

Author Affiliations

1 Experimental Immunopathology Laboratory, Department of Biological Sciences, College of Sciences, São Paulo State University, UNESP, Bauru, SP, 17047-001, Brazil

2 Botucatu Medical School, São Paulo State University, UNESP, Botucatu, SP, 18618-970, Brazil

3 Instituto Lauro de Souza Lima, Bauru, SP, 17034-971, Brazil

For all author emails, please log on.

BMC Infectious Diseases 2009, 9:98  doi:10.1186/1471-2334-9-98

Published: 17 June 2009

Abstract

Background

In order to attain a better understanding of the interactions between opportunist fungi and their hosts, we investigated the cytokine profile associated with the inflammatory response to Candida albicans infection in mice with solid Ehrlich tumors of different degrees.

Methods

Groups of eight animals were inoculated intraperitoneally with 5 × 106 C. albicans 7, 14 or 21 days after tumor implantation. After 24 or 72 hours, the animals were euthanized and intraperitoneal lavage fluid was collected. Peritoneal macrophages were cultivated and the levels of IFN-γ, TNF-α, IL-12, IL-10 and IL-4 released into the supernatants were measured by ELISA. Kidney, liver and spleen samples were evaluated for fungal dissemination. Tumor-free animals and animals that had only been subjected to C. albicans infection were used as control groups.

Results

Our results demonstrated that the mice produced more IFN-γ and TNF-α and less IL-10, and also exhibited fungal clearance, at the beginning of tumor evolution. With the tumor progression, this picture changed: IL-10 production increased and IFN-γ and TNF-α release decreased; furthermore, there was extensive fungal dissemination.

Conclusion

Our results indicate that solid tumors can affect the production of macrophage cytokines and, in consequence, affect host resistance to opportunistic infections.